Shinya Fukunishi
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research, Hepatitis C virus research, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Metabolic Syndrome and Sarcopenia(2021)282 cited
- → Pathophysiology and mechanisms of primary sarcopenia (Review)(2021)216 cited
- → Cancer Cachexia: Its Mechanism and Clinical Significance(2021)214 cited
- → Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis(2022)128 cited
- → Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population(2022)126 cited
- → Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction(2015)106 cited
- → Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib(2020)95 cited
- → Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats(2013)87 cited
- → Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study(2022)77 cited
- → Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice(2022)77 cited